Fundraising Fox
Laurent Jespers
InvestorEntrepreneur in Residence (EIR) at Cambridge Innovation Capital
Find your path to Laurent
Sign up to see every warm intro you have to Laurent
- Paths you didn't know you had: your email and LinkedIn already hold routes to Laurent. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Laurent Jespers has around 25 years of experience in discovery and early-stage clinical development across multiple therapeutic modalities and disease areas. He previously served as Chief Scientific Officer at Xap Therapeutics, held a Vice President role in Biopharmaceuticals and Cell & Gene Therapy at GSK, and was an early employee at Domantis Ltd (later acquired by GSK). He holds an MSc in Chemistry and a PhD in Biochemistry from the University of Leuven, Belgium, and is an alumnus of the MRC Laboratory of Molecular Biology.
Invests in
Biotech
Colleagues at Cambridge Innovation Capital
Frequently asked questions
- Who is Laurent Jespers?
- Laurent Jespers has around 25 years of experience in discovery and early-stage clinical development across multiple therapeutic modalities and disease areas. He previously served as Chief Scientific Officer at Xap Therapeutics, held a Vice President role in Biopharmaceuticals and Cell & Gene Therapy at GSK, and was an early employee at Domantis Ltd (later acquired by GSK). He holds an MSc in Chemistry and a PhD in Biochemistry from the University of Leuven, Belgium, and is an alumnus of the MRC Laboratory of Molecular Biology.
- Where does Laurent Jespers work?
- Laurent Jespers is Entrepreneur in Residence (EIR) at Cambridge Innovation Capital.
- What does Laurent Jespers invest in?
- Laurent Jespers invests in Biotech.
About this profile. Compiled from public sources — Cambridge Innovation Capital's own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights